VistaGen TherapeuticsVTGN 
$3.36-3.72%24h
-3.72%24h
Global rank21794
Market cap$23.38M
Change 7d-4.55%
YTD Performance-33.47%
SP500 benchmarkUnderperform
P/E-0.39
P/S-102.88
Revenue-$227.30K
Earnings-$59.25M
Dividend yield-
Main Sector
Healthcare
Category
VistaGen Therapeutics Revenue data
According to VistaGen Therapeutics latest financial reports the company had revenue of $-227.30K in 2023-03-31, a -120.50% decrease from 2022. VistaGen Therapeutics highest revenue was $1.11M in 2022.
Revenue history for VistaGen Therapeutics from 2020 to 2024
-
Value:-
VistaGen Therapeutics revenue by year
| Year | Revenue | Change |
|---|---|---|
| 2023 | $-227.30K | -120.50% |
| 2022 | $1.11M | 1.78% |
| 2021 | $1.09M | Infinity% |
| 2020 | $0 | - |
View the top revenue stocks 
